Business
Psycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor
Psycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor.
About this update from Blue Water Ventures International, Inc.
[{"type":"text","content":"\n\n\n\nPsycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nPsycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor\nPR Newswire\nMIAMI, May 10, 2022\n\n\n\nFamed entrepreneur excited about the company's development of psychedelic pharmaceutical medicines to treat the widespread mental health crisis\nMIAMI, May 10, 2022 /PRNewswire/ -- Psycheceutical, Inc. (a wholly owned subsidiary of Psycheceutical Bioscience, Inc. (OTC: BWVI), a biopharmaceutical company dedicated to the development and commercialization of psychedelic medicines, today announced the addition of original Shark Tank entrepreneur Kevin Harrington as the corporation's newest investor and strategic advisor. Harrington joins Psycheceutical to provide expertise on the strategy, direction, and execution of the company's growth and development in pursuit of its mission to accelerate the research, availability, and delivery of safer and more effective psychedelic pharmaceutical medicines.\n\"The world is undergoing an unprecedented mental health crisis. We all know someone who is suffering from depression, anxiety, or addiction. What we've been doing isn't working,\" said Harrington. \"We need a different approach to treatment, and psychedelic medicines have shown incredible promise where conventional medicines have failed. It seems clear to me that psychedelics are the future of mental health treatment, but they need to be delivered safely like pharmaceutical medicines, which is why I'm so excited about Psycheceutical.\"\n\"I've been watching the emerging psychedelic medicine industry and looking for investment opportunities. I chose to invest in and join Psycheceutical because of their patented next-generation delivery technologies, designed to increase the safety and efficacy of psychedelic compounds without the hallucinogenic side effects. As an entrepreneur who is trying to help people and make a positive...